Literature DB >> 22831788

Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses.

I Bombin1, M Mayoral, J Castro-Fornieles, A Gonzalez-Pinto, E de la Serna, M Rapado-Castro, S Barbeito, M Parellada, I Baeza, M Graell, B Payá, C Arango.   

Abstract

BACKGROUND: The longitudinal neuropsychological study of first-episode early-onset psychosis (EOP) patients, whose brain maturation is still in progress at the time of illness onset, provides a unique opportunity to compare their cognitive development with that of healthy subjects, in search of specific patterns resulting from the interaction between neurodevelopmental processes and the presence of psychotic disorders. Method Seventy-five first-episode EOP patients (schizophrenia n = 35; bipolar disorder n = 17; other forms of psychosis n = 23) with a mean age of 15.53 years were assessed with a neuropsychological battery that included measures of attention, working memory, memory and executive functions within 6 months following the onset of the first psychotic symptom (baseline) and 2 years later. Psychotic symptoms were assessed at both times with the Positive and Negative Symptom Scale (PANSS). Seventy-nine healthy subjects matched for age and education served as controls.
RESULTS: EOP patients showed significant cognitive impairment at both baseline and the 2-year follow-up, with no significant differences between diagnostic groups at either time. Both healthy controls and EOP patients improved in all cognitive measures, except for patient working memory. Improvement in patient attention lost significance after controlling for psychotic symptom reduction. No significant time/diagnosis interaction was found among patients (p > 0.405).
CONCLUSIONS: Cognitive impairment in EOP is already present at the first episode, and cognitive development seems to be arrested early in EOP patients compared to their healthy peers, at least for some cognitive functions. These and previous similar results support the neurodevelopmental hypothesis of psychosis.

Entities:  

Mesh:

Year:  2012        PMID: 22831788     DOI: 10.1017/S0033291712001535

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  18 in total

1.  Peptide sharing between influenza A H1N1 hemagglutinin and human axon guidance proteins.

Authors:  Guglielmo Lucchese; Giovanni Capone; Darja Kanduc
Journal:  Schizophr Bull       Date:  2013-01-31       Impact factor: 9.306

2.  Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia.

Authors:  Buranee Kanchanatawan; Solaphat Hemrungrojn; Supaksorn Thika; Sunee Sirivichayakul; Kiat Ruxrungtham; André F Carvalho; Michel Geffard; George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2017-09-05       Impact factor: 5.590

Review 3.  Neuroprogression and Cognitive Functioning in Bipolar Disorder: A Systematic Review.

Authors:  Taiane Cardoso; Isabelle E Bauer; Thomas D Meyer; Flavio Kapczinski; Jair C Soares
Journal:  Curr Psychiatry Rep       Date:  2015-09       Impact factor: 5.285

4.  Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study.

Authors:  A M Sánchez-Torres; L Moreno-Izco; R Lorente-Omeñaca; B Cabrera; A Lobo; A M González-Pinto; J Merchán-Naranjo; I Corripio; E Vieta; E de la Serna; A Butjosa; F Contreras; S Sarró; G Mezquida; M Ribeiro; M Bernardo; M J Cuesta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-11-21       Impact factor: 5.270

Review 5.  Neurocognitive functioning in euthymic patients with bipolar disorder and unaffected relatives: A review of the literature.

Authors:  Stephanie A Cardenas; Layla Kassem; Melissa A Brotman; Ellen Leibenluft; Francis J McMahon
Journal:  Neurosci Biobehav Rev       Date:  2016-08-05       Impact factor: 8.989

6.  Differential subcellular localization of the glucocorticoid receptor in distinct neural stem and progenitor populations of the mouse telencephalon in vivo.

Authors:  Maria A Tsiarli; A Paula Monaghan; Donald B Defranco
Journal:  Brain Res       Date:  2013-06-07       Impact factor: 3.252

7.  Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders.

Authors:  Celso Arango; David Fraguas; Mara Parellada
Journal:  Schizophr Bull       Date:  2013-12-26       Impact factor: 9.306

8.  Body mass, cardiovascular risk and metabolic characteristics of young persons presenting for mental healthcare in Sydney, Australia.

Authors:  Elizabeth M Scott; Daniel F Hermens; Django White; Sharon L Naismith; Jeanne GeHue; Bradley G Whitwell; Nick Glozier; Ian B Hickie
Journal:  BMJ Open       Date:  2015-03-27       Impact factor: 2.692

9.  Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables.

Authors:  Miao Yu; XiaoWei Tang; Xiang Wang; XiangRong Zhang; XiaoBin Zhang; WeiWei Sha; ShuQiao Yao; Ni Shu; XiangYang Zhang; ZhiJun Zhang
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

10.  Evaluating differential developmental trajectories to adolescent-onset mood and psychotic disorders.

Authors:  Ian B Hickie; Daniel F Hermens; Sharon L Naismith; Adam J Guastella; Nick Glozier; Jan Scott; Elizabeth M Scott
Journal:  BMC Psychiatry       Date:  2013-11-12       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.